SI1636389T1 - Brezplazmidni klon E. coli sev DSM 6601 - Google Patents

Brezplazmidni klon E. coli sev DSM 6601

Info

Publication number
SI1636389T1
SI1636389T1 SI200430907T SI200430907T SI1636389T1 SI 1636389 T1 SI1636389 T1 SI 1636389T1 SI 200430907 T SI200430907 T SI 200430907T SI 200430907 T SI200430907 T SI 200430907T SI 1636389 T1 SI1636389 T1 SI 1636389T1
Authority
SI
Slovenia
Prior art keywords
plasmid
coli strain
strain dsm
free clone
clone
Prior art date
Application number
SI200430907T
Other languages
English (en)
Inventor
Jorg Hacker
Tobias Oelschlaeger
Sibylle Oswald
Ulrich Sonnenborn
Hans Proppert
Original Assignee
Pharma Zentrale Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Zentrale Gmbh filed Critical Pharma Zentrale Gmbh
Publication of SI1636389T1 publication Critical patent/SI1636389T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI200430907T 2003-06-26 2004-06-25 Brezplazmidni klon E. coli sev DSM 6601 SI1636389T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10328669A DE10328669B4 (de) 2003-06-26 2003-06-26 Plasmidfreier Klon des E. coli Stammes DSM 6601
EP04740297A EP1636389B1 (de) 2003-06-26 2004-06-25 Plasmidfreier klon des e. coli-stammes dsm 6601
PCT/EP2004/006886 WO2004113575A1 (de) 2003-06-26 2004-06-25 Plasmidfreier klon des e. coli-stammes dsm 6601

Publications (1)

Publication Number Publication Date
SI1636389T1 true SI1636389T1 (sl) 2009-02-28

Family

ID=33520989

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200430907T SI1636389T1 (sl) 2003-06-26 2004-06-25 Brezplazmidni klon E. coli sev DSM 6601

Country Status (20)

Country Link
US (1) US7993902B2 (sl)
EP (1) EP1636389B1 (sl)
JP (1) JP2009514506A (sl)
KR (1) KR100654029B1 (sl)
CN (1) CN100395328C (sl)
AT (1) ATE412072T1 (sl)
AU (1) AU2004249888B2 (sl)
CA (1) CA2496080C (sl)
DE (2) DE10328669B4 (sl)
DK (1) DK1636389T3 (sl)
ES (1) ES2314407T3 (sl)
HK (1) HK1079994B (sl)
IL (1) IL167067A (sl)
NZ (1) NZ541192A (sl)
PL (1) PL1636389T3 (sl)
PT (1) PT1636389E (sl)
SI (1) SI1636389T1 (sl)
TW (1) TWI284150B (sl)
WO (1) WO2004113575A1 (sl)
ZA (1) ZA200501194B (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102229898B (zh) * 2011-05-06 2012-11-14 首都医科大学附属北京友谊医院 用于治疗菌群失调症菌群紊乱症的大肠埃希氏菌、制剂及其制备方法
CN113046285A (zh) 2012-04-06 2021-06-29 康奈尔大学 用于稳健的体液及细胞免疫应答的亚单位疫苗递送平台
CN103740747A (zh) * 2014-02-08 2014-04-23 扬州大学 一种使用自杀性载体去除大肠杆菌Nissle菌内隐秘质粒的方法
US20230232882A1 (en) 2020-06-05 2023-07-27 Institut National de Recherche Pour I'Agriculture, I'Alimentation et I'Environnement Use of E. coli strains expressing high level of alpha-Gal to modulate immunity and provide protection against infectious diseases in animals
CN111850026A (zh) * 2020-08-07 2020-10-30 南开大学 一种利用整合自杀载体高效特异性清除细菌中质粒的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686184A (en) * 1983-07-01 1987-08-11 Lubrizol Genetics, Inc. Gene transfer vector
DE19713543B4 (de) * 1997-04-02 2007-01-11 Pharma-Zentrale Gmbh Bakterielle Plasmide
DE19751907B4 (de) * 1997-11-22 2004-07-08 Pharma-Zentrale Gmbh Verwendung von Escherichia coli Stamm DSM 6601 zur Behandlung von Diarrhoeen auf dem Veterinärsektor
EP1208190A4 (en) * 1999-06-22 2003-07-02 Invitrogen Corp Fast growing microorganisms for biotechnological applications
DE10013539B4 (de) * 2000-03-20 2006-07-13 Pharma-Zentrale Gmbh Lipopolysaccharide aus Escherichia coli, Verfahren zu deren Herstellung und deren Verwendungen

Also Published As

Publication number Publication date
DE10328669A1 (de) 2005-02-03
HK1079994B (zh) 2009-02-06
KR100654029B1 (ko) 2006-12-05
DE10328669B4 (de) 2005-12-01
KR20050093757A (ko) 2005-09-23
CN1700925A (zh) 2005-11-23
ZA200501194B (en) 2005-10-26
ES2314407T3 (es) 2009-03-16
JP2009514506A (ja) 2009-04-09
NZ541192A (en) 2007-02-23
CA2496080A1 (en) 2004-12-29
CA2496080C (en) 2010-01-26
PL1636389T3 (pl) 2009-06-30
US7993902B2 (en) 2011-08-09
AU2004249888A1 (en) 2004-12-29
AU2004249888B2 (en) 2006-10-26
HK1079994A1 (en) 2006-04-21
CN100395328C (zh) 2008-06-18
ATE412072T1 (de) 2008-11-15
TW200513530A (en) 2005-04-16
TWI284150B (en) 2007-07-21
EP1636389B1 (de) 2008-10-22
DK1636389T3 (da) 2009-02-16
IL167067A (en) 2010-04-29
WO2004113575A1 (de) 2004-12-29
DE502004008323D1 (de) 2008-12-04
US20060094117A1 (en) 2006-05-04
PT1636389E (pt) 2008-12-26
EP1636389A1 (de) 2006-03-22

Similar Documents

Publication Publication Date Title
MXPA03008121A (es) 5-fenilpirimidinas, metodos y productos intermedios para su produccion y uso de las mismas para controlar hongos patogenicos.
WO2003104473A8 (de) Galactosyl-isomalt, verfahren zu seiner herstellung und verwendung
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
IL166710A0 (en) Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile
YU63202A (sh) Derivati 2-okso-1-pirolidina, postupci za njihovo dobijanje i njihove upotrebe
WO2003093269A3 (de) Substituierte pyrazolo-pyrimidin-4-one
AU2002316982A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
AU2002319249A1 (en) Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators
MY147478A (en) Microbiologically stabilised beer
RS20060250A (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, method for the production thereof, and their use as antiphlogistics
WO2003082208A3 (en) Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
WO2004033659A3 (en) Novel tumor suppressor gene and compositions and methods for making and using the same
HK1079994A1 (en) Plasmid-free clone of E coli strain DSM 6601
WO2003060017A3 (de) Stabilisierte wässrige polyurethan-polyharnstoff dispersionen
WO2004007664A3 (en) Nucleic acid vectors
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
UA83203C2 (uk) Тіазол-(бі)циклоалкілкарбоксаніліди, засіб на їх основі та застосування для боротьби з небажаними мікроорганізмами
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
WO2002060483A3 (en) Perylenequinones for use as photosensitizers and sonosensitizers
EP1431388A3 (en) A method for direct cloning of nuclease genes in E.Coli
MXPA03010498A (es) Proceso para la preparacion de imipenem.
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
WO2004021992A3 (en) Delivery of therapeutics to the brain and spinal cord
MXPA05012363A (es) Poliisocianatos bloqueados estables en la solidificacion.